SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bitcoin is the world's first decentralized cryptocurrency, created in 2009 by the pseudonymous Satoshi Nakamoto. It enables peer-to-peer electronic cash transactions without intermediaries like banks or governments, operating on a blockchain secured by Proof of Work mining and the SHA-256 cryptographic algorithm.   With a fixed supply cap of 21 million coins and programmatic halvings every four years that reduce miner rewards, Bitcoin is designed as a deflationary digital asset often called "digital gold." Its value stems from solving the double-spending problem without trusted intermediaries, creating the first truly scarce digital asset with censorship resistance and permissionless access that no government, corporation, or individual can control.  Bitcoin operates as a decentralized peer-to-peer network where transactions are recorded on a public ledger called the blockchain, distributed across thousands of computers globally. Transactions are grouped into blocks added approximately every 10 minutes through mining, where specialized computers compete to solve complex mathematical puzzles.   Bitcoin has achieved mainstream adoption through multiple vectors. The January 2024 SEC approval of 11 spot Bitcoin ETFs opened Bitcoin investment to traditional finance participants, and corporations like Strategy (formerly MicroStrategy) are using Bitcoin as a treasury reserve asset to protect against currency debasement, offering MSTR holders amplified exposure to Bitcoin.   The Bitcoin ecosystem continues to evolve with innovations like Ordinals, which emerged in January 2023 to enable NFT-like functionality directly on Bitcoin, and BRC-20 tokens, an experimental standard for creating fungible tokens using Ordinal inscriptions. BTCFi (Bitcoin Finance) represents emerging financial applications extending beyond Bitcoin's traditional role, with protocols like Babylon allowing Bitcoin holders to stake BTC to secure Proof of Stake chains.

Bitcoin

Bitcoin is seeing intense community debate as bulls target a breakthrough of the 80k level while bears express skepticism about the sustainability of recent price action. Conversations are dominated by discussions around institutional accumulation, market liquidity, and broader geopolitical tensions influencing trading sentiment.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Kendu is trending as the community doubles down on its brandcoin strategy, aggressively promoting real-world products like spice, energy drinks, and apparel to establish a tangible ecosystem. Investors are actively discussing the project's consistent growth and permissionless brand model, with many emphasizing a long-term 'build and hold' conviction rather than short-term trading.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

Onyxcoin is seeing intense community discussion surrounding the upcoming Goliath mainnet launch, with investors debating whether the network update will act as a major catalyst for adoption or a classic 'sell-the-news' event. Sentiment remains sharply divided, as long-term holders focus on potential enterprise utility and staking opportunities while vocal critics highlight the lack of confirmed partnerships and historical price volatility.

QUALCOMM, Inc. engages in developing and commercializing foundational technologies and products used in mobile devices and other wireless products. It operates through the following segments: Qualcomm CDMA Technologies (QCT), Qualcomm Technology Licensing (QTL), and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses and provides rights to use portions of the firm's intellectual property portfolio. The QSI segment focuses on opening new or expanding opportunities for its technologies and supporting the design and introduction of new products and services for voice and data communications. The company was founded by Franklin P. Antonio, Adelia A. Coffman, Andrew Cohen, Klein Gilhousen, Irwin Mark Jacobs, Andrew J. Viterbi, and Harvey P. White in July 1985 and is headquartered in San Diego, CA.

Qualcomm, Inc.

Qualcomm is trending as investors react to a significant revenue outlook miss, with the company citing memory supply constraints and slowing smartphone demand as key headwinds impacting near-term growth. The community is actively debating whether this decline represents a buying opportunity for a long-term AI-focused play or a structural setback given the company's historical reliance on handset markets.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is seeing massive momentum and high-volume trading driven by increasing investor confidence in its role within the AI optical interconnect sector, with many community members pointing to potential hyperscaler connections as a major catalyst. Despite significant short-seller skepticism, the stock has experienced a strong upward surge, fueling active debate between those anticipating a sustained breakout and others warning of a speculative bubble.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently surging due to a critical clinical trial milestone, with investors closely watching the upcoming Phase 3 readout for its gene-editing therapy and the implications for the broader biotech sector. The community is actively debating the stock's high short interest and potential for a squeeze against the backdrop of significant regulatory de-risking and positive long-term clinical data.

Atomera, Inc. engages in the development, commercialization, and licensing of proprietary processes and technologies for the semiconductor industry. It developed Mears Silicon Technology, which increases performance and power efficiency in semiconductor transistors. The company was founded by Robert Mears on November 26, 2001 and is headquartered in Los Gatos, CA.

Atomera Inc

Atomera is seeing heightened investor attention driven by speculation that its quantum-engineered MST technology is nearing commercialization with major chipmakers following recent collaborative updates. While bulls are pinning hopes on a potential short squeeze and upcoming deal announcements, the community remains divided between long-term believers in the company's patent potential and skeptics frustrated by the lack of sustained revenue.

Lido DAO

Lido DAO is currently a major focal point for traders evaluating Ethereum's liquid staking sector, with community discussion centering on potential governance proposals for token buybacks and debates regarding its dominance against emerging competitors. Investors remain actively divided, with many analyzing the protocol's deep liquidity and institutional integrations against ongoing concerns about market volatility and bearish price action.

Himax Technologies, Inc. is a semiconductor solution provider dedicated to display imaging processing technologies. It operates through the Driver Integrated Circuit and Non-Driver Products segments. The company's products include display drivers, timing controllers, wafer level optics, video and display technology solutions, liquid crystal over silicon silicon, complementary metal-oxide semiconductor image sensor, and power integrated circuit. Its products used in TVs, laptops, monitors, mobile phones, tablets, digital cameras, car navigation, virtual reality (VR) devices and many other consumer electronics devices. Himax Technologies was founded by Biing Seng Wu and Jordan Wu on June 12, 2001 and is headquartered in Tainan, Taiwan.

Himax Technologies - ADR

Himax Technologies, Inc.

Himax Technologies is trending as community members closely monitor its critical role in the Co-Packaged Optics (CPO) market, with increasing discussion centered on its potential as a stealth supplier for major AI infrastructure. Investors are actively debating the stock's technical price action and technical setups, weighing the impact of strategic supply chain partnerships against historical skepticism regarding management's ability to capitalize on long-term growth opportunities.

Oklo, Inc. engages in the development of fission reactors. It provides clean energy through the design and deployment of fast fission power plants. The company was founded by Jacob DeWitte and Caroline Cochran on July 3, 2013 and is headquartered in Santa Clara, CA.

Oklo Inc. - Ordinary Shares - Class A

Oklo Inc.

Oklo is trending as investors rally around its AI-driven energy narrative, fueled by a new strategic collaboration with Nvidia and Los Alamos National Laboratory to develop nuclear-powered AI data centers. The community is actively debating the company's long-term commercialization timeline and fuel recycling prospects while monitoring for major upcoming regulatory and operational milestones.

statis crypto Watchlist

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

A researcher works in the clinical-stage biopharmaceutical company Xencors new laboratory in Pasadena. (Photo by Sarah Reingewirtz/MediaNews Group/Los Angeles Daily News via Getty Images)

Nano-Cap Regentis Biomaterials Stock Is Up Nearly 15% This Year: Why Retail Traders Are Swarming It

Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits.

Equity

Heading to close this week as its best week since IPO, RGNT has become a retail favorite with surging followers on Stocktwits.


Regentis Biomaterials Ltd. engages in the development of tissue repair solutions. It focuses on orthopedic treatments through its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue such as inflamed cartilage and bone tissue. The company was founded by Dror Seliktar and Tal Yehiel on September 1, 2004 and is headquartered in Or-Akiva, Israel.

Current Price	$3.09
Prev Close	$3.08
Open	$2.73
Dividend Yield	0.00%
50-Day Moving Average	$3.34
Beta	1.47
Avg. Volume	5,564.77
PE Ratio	-1.16

52-Week High	$8.35
52-Week Low	$2.73
Market Capitalization	$16M
EPS (Annual)	-$2.64
Price to Book	3.37
Revenue Per Employee	$0.00

RGNT
Regentis Biomaterials

Feed

News

Sentiment

Fundamentals

Info

Latest RGNT News

RGNTRegentis Biomaterials